Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy

BACKGROUND: The value of anti-phospholipase A2 receptor antibody (anti-PLA2R ab) monitoring at 3 months after diagnosis in membranous nephropathy (MN) remains uncertain. METHODS: We retrospectively examined the outcome on 1 August 2020 of 59 adult patients (age 54 (44, 68) years, 69% male, SCr 1.0 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefan, Gabriel, Stancu, Simona, Zugravu, Adrian, Popa, Otilia, Zubidat, Dalia, Petre, Nicoleta, Mircescu, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863379/
https://www.ncbi.nlm.nih.gov/pubmed/35172682
http://dx.doi.org/10.1080/0886022X.2022.2033265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863379/
https://www.ncbi.nlm.nih.gov/pubmed/35172682
http://dx.doi.org/10.1080/0886022X.2022.2033265

Ejemplares similares